DIVI S LABORATORIES LTD vs ERIS LIFESCIENCES LIMITED

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and ERIS LIFESCIENCES LIMITED (ERIS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

DIVI S LABORATORIES LTD and ERIS LIFESCIENCES LIMITED are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
32.54
10.72
P/B ratio
5.14
0.44%
Dividend yield
0.50%
₹96.73
EPS
₹44.72

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
18.70%
22.00%
Return on capital
14.00%
33.00%
EBITDA margin
36.00%
24.32%
Net margin
20.71%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
22.91%
12.10%
Profit CAGR (3Y)
20.11%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹20,154 Cr
₹10,560 Cr
Revenue
₹3,129 Cr
₹2,568 Cr
Net profit
₹648 Cr
0.00
Debt / equity
0.60
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
ERIS LIFESCIENCES LIMITED
  • ["Stock is trading at 5.08 times its book value", "Promoter holding has decreased over last quarter: -0.93%", "Tax rate seems low"]
DIVI S LABORATORIES LTD full analysis ERIS LIFESCIENCES LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVI S LABORATORIES LTD vs ERIS LIFESCIENCES LIMITED: Share Price, Valuation & Which to Buy | DocStoX